Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000899243-20-003354)

Filing Details

Accession Number:: 0000899243-20-003354
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-02-05 17:55:27
Reporting Period:: 2020-02-03

Accepted Time:: 2020-02-05 17:55:27
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1701541	Black Diamond Therapeutics Inc.	BDTX	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1637054	Brent Hatzis-Schoch	C/O Black Diamond Therapeutics, Inc. 139 Main Street Cambridge MA 02142	See Remarks	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-02-03	3,000	$19.00	3,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

On February 3, 2020, Reporting Person purchased 3,000 shares of Common Stock of the Issuer at a price of $19.00 per share pursuant to an underwritten public offering.